3M CO Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
3M CO (MMM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $25.33 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2021-04-27
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-03-31 was $25.33.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $21.58, a 36.88% decline from fiscal 2019.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $34.19, a 17.79% decline from fiscal 2018.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $41.59, a 76.90% increase from fiscal 2017.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $23.51, a 4.63% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2021-03-31 | $25.33 10-Q · filed 2021-04-27 | |||
| 2020-12-31 | $21.58 10-K · filed 2021-02-04 | |||
| 2019-12-31 | $34.19 10-K · filed 2021-02-04 | |||
| 2018-12-31 | $41.59 10-K · filed 2021-02-04 | |||
| 2017-12-31 | $23.51 10-K · filed 2020-02-06 | |||
| 2016-12-31 | $22.47 10-K · filed 2019-02-07 | |||
| 2015-12-31 | $23.98 8-K · filed 2018-05-08 | |||
| 2014-12-31 | $19.63 8-K · filed 2017-05-04 | |||
| 2010-09-30 | $16.50 10-Q · filed 2010-11-05 | |||
| 2010-06-30 | $16.50 10-Q · filed 2010-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |